NDC codes

FDA NDC Directory
Product NDC (as listed)54738-005Labeler and product segments. Claims need a package NDC.
Product NDC at billing width54738-0005Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
54738-005-4254738000542420 mL in 1 BOTTLE (54738-005-42)Marketed from May 22, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Sucralfate
Generic name (nonproprietary)
sucralfate
Active ingredients
Sucralfate — 1 g/10mL
Dosage form
Suspension
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 216726
Marketing start
Listing expires
Other FDA classes
Organometallic Compounds (Chemical structure)
Identifiers
Product ID 54738-005_35d366c4-22fb-2cca-e063-6394a90a6980SPL ID 35d366c4-22fb-2cca-e063-6394a90a6980SPL set ID 7ac10c3f-9d50-4702-900c-41075ac6f896RxCUI 313123UNII XX73205DH5
Pharmacologic class
Aluminum Complex

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N454738000542 followed by a unit qualifier and the quantity

Package 54738-0005-42. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Sucralfate Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216726

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216726
ProductStrengthForm · routeLabelerProduct NDC
SucralfateSucralfate 1 g/10mLSuspensionOralTorrent Pharmaceuticals Limited13668-754

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in